FR2281123A1 - Oxo-20 pregnanes et medicaments qui en contiennent - Google Patents

Oxo-20 pregnanes et medicaments qui en contiennent

Info

Publication number
FR2281123A1
FR2281123A1 FR7524225A FR7524225A FR2281123A1 FR 2281123 A1 FR2281123 A1 FR 2281123A1 FR 7524225 A FR7524225 A FR 7524225A FR 7524225 A FR7524225 A FR 7524225A FR 2281123 A1 FR2281123 A1 FR 2281123A1
Authority
FR
France
Prior art keywords
pregnanes
oxo
products containing
medicinal products
medicinal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR7524225A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of FR2281123A1 publication Critical patent/FR2281123A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
    • C07J7/002—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
FR7524225A 1974-08-05 1975-08-04 Oxo-20 pregnanes et medicaments qui en contiennent Withdrawn FR2281123A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2438020A DE2438020A1 (de) 1974-08-05 1974-08-05 18-methyl-19-nor-20-keto-pregnane und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
FR2281123A1 true FR2281123A1 (fr) 1976-03-05

Family

ID=5922668

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7524225A Withdrawn FR2281123A1 (fr) 1974-08-05 1975-08-04 Oxo-20 pregnanes et medicaments qui en contiennent

Country Status (17)

Country Link
US (1) US4029777A (fr)
JP (1) JPS5141347A (fr)
AT (1) AT345998B (fr)
BE (1) BE832124A (fr)
CA (1) CA1037027A (fr)
CH (1) CH611910A5 (fr)
CS (2) CS175500B2 (fr)
DD (1) DD120192A5 (fr)
DE (1) DE2438020A1 (fr)
DK (1) DK136369C (fr)
ES (1) ES439720A1 (fr)
FR (1) FR2281123A1 (fr)
GB (1) GB1512258A (fr)
HU (1) HU171684B (fr)
IL (1) IL47770A (fr)
NL (1) NL7509326A (fr)
SE (1) SE404804B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0382790A1 (fr) * 1987-08-25 1990-08-22 GEE, Kelvin W. Compositions et procedes soulageant le stress, l'anxiete et l'activite apoplectique

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61144199A (ja) * 1984-12-18 1986-07-01 Pioneer Electronic Corp スピ−カ用紙製振動部材の製造方法
US5232917A (en) * 1987-08-25 1993-08-03 University Of Southern California Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series
US5175154A (en) * 1987-11-25 1992-12-29 Research Corporation Technologies, Inc. 5 α-pregnan-20-ones and 5-pregnen-20-ones and related compounds
WO2014169836A1 (fr) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor-stéroïdes neuroactifs et procédés d'utilisation de ceux-ci
HUE051403T2 (hu) 2013-04-17 2021-03-01 Sage Therapeutics Inc Neuroaktív 19-nor-szteroidok kezelési eljárásokhoz
KR20230172622A (ko) 2013-04-17 2023-12-22 세이지 테라퓨틱스, 인크. 19-노르 c3,3-이치환된 c21-n-피라졸릴 스테로이드 및 그의 사용 방법
US9725481B2 (en) 2013-04-17 2017-08-08 Sage Therapeutics, Inc. 19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof
PT3021852T (pt) 2013-07-19 2021-04-21 Sage Therapeutics Inc Esteroides neuroativos, composições e utilizações das mesmas
CA2921512A1 (fr) 2013-08-23 2015-02-26 Sage Therapeutics, Inc. Steroides neuroactifs, compositions et utilisations
WO2015195962A1 (fr) 2014-06-18 2015-12-23 Sage Therapeutics, Inc. Stéroïdes neuroactifs, leurs compositions et utilisations
HUE051488T2 (hu) 2014-10-16 2021-03-01 Sage Therapeutics Inc Készítmények és eljárások központi idegrendszeri rendellenességek kezelésére
US10577390B2 (en) 2014-10-16 2020-03-03 Sage Therapeutics, Inc. Compositions and methods for treating CNS disorders
EP3719029A1 (fr) 2014-11-27 2020-10-07 Sage Therapeutics, Inc. Compositions pour l'induction de la sédation
DK3250210T3 (da) 2015-01-26 2021-03-08 Sage Therapeutics Inc Sammensætninger og fremgangsmåder til behandling af cns-forstyrrelser
US10329320B2 (en) 2015-02-20 2019-06-25 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
RU2019103590A (ru) 2016-07-11 2021-02-11 Сейдж Терапьютикс, Инк. С17-, с20- и с21-замещенные нейроактивные стероиды и способы их применения
IL275562B1 (en) * 2017-12-22 2024-03-01 Sage Therapeutics Inc Preparations and methods for the treatment of central nervous system disorders
JP2022534424A (ja) 2019-05-31 2022-07-29 セージ セラピューティクス， インコーポレイテッド 神経刺激性ステロイド及びその組成物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE791196A (fr) * 1971-11-11 1973-05-10 Glaxo Lab Ltd Nouveaux steroides, leur procede de preparation et leurs applications
GB1409239A (en) * 1971-11-11 1975-10-08 Glaxo Lab Ltd Process for the preparation of 3alpha-hydroxy-5alpha-steroids

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0382790A1 (fr) * 1987-08-25 1990-08-22 GEE, Kelvin W. Compositions et procedes soulageant le stress, l'anxiete et l'activite apoplectique
EP0382790A4 (en) * 1987-08-25 1991-03-27 Kelvin W. Gee Compositions and methods for alleviating stress, anxiety and seizure activity

Also Published As

Publication number Publication date
BE832124A (fr) 1976-02-05
DD120192A5 (fr) 1976-06-05
HU171684B (hu) 1978-02-28
IL47770A0 (en) 1975-10-15
ES439720A1 (es) 1977-03-01
DE2438020A1 (de) 1976-02-26
AT345998B (de) 1978-10-10
SE404804B (sv) 1978-10-30
CS175500B2 (fr) 1977-05-31
CA1037027A (fr) 1978-08-22
AU8351575A (en) 1977-02-03
IL47770A (en) 1978-10-31
GB1512258A (en) 1978-05-24
CS175498B2 (fr) 1977-05-31
US4029777A (en) 1977-06-14
DK136369B (da) 1977-10-03
SE7508777L (sv) 1976-02-06
JPS5141347A (en) 1976-04-07
DK344475A (da) 1976-02-06
NL7509326A (nl) 1976-02-09
CH611910A5 (fr) 1979-06-29
DK136369C (da) 1978-02-27
ATA600475A (de) 1978-02-15

Similar Documents

Publication Publication Date Title
BE846335R (fr) (polyalcoxy-phenyl)-4-pyrrolidinones-2 et medicaments qui en contiennent
BE860877A (fr) Spirolactones steroidiques et medicaments qui en contiennent
BE826923A (fr) (polyacoxy-phenyl)-4-pyrrolidinones-2 medicaments qui en contiennent
FR2295739A1 (fr) Oxo-20 homopregnanes et medicaments qui en contiennent
FR2281123A1 (fr) Oxo-20 pregnanes et medicaments qui en contiennent
FR2326927A1 (fr) Steroides insatures en 15 et medicaments qui en contiennent
FR2312240A1 (fr) Derives du prostane et medicaments qui en contiennent
FR2336129A1 (fr) Ethers d'imidazolyl-oximes et medicaments qui en contiennent
FR2316943A1 (fr) Pyrrolidones et medicaments qui en contiennent
FR2280380A1 (fr) Derives du benzimidazole et medicaments qui en contiennent
BE852089A (fr) Androstenones et medicaments qui en contiennent
FR2287224A1 (fr) Derives de la pyridine et medicaments qui en contiennent
FR2287909A1 (fr) Hydroxy-1a steroides et medicaments qui en contiennent
FR2287908A1 (fr) Hydroxy-7 oestradiols et medicaments qui en contiennent
BE800005A (fr) Phenoxy-1 amino-3 propanols-2 et medicaments qui en contiennent
FR2307526A1 (fr) Oxo-11 prostaglandines et medicaments qui en contiennent
BE788322A (fr) 3,4-dihydro-2h-isoquinoleine-1-ones et medicaments qui en contiennent
BE849346R (fr) Pyrrolidones et medicaments qui en contiennent
FR2290214A1 (fr) Methylene-steroides et medicaments qui en contiennent
FR2316941A1 (fr) Pyrrolidones et medicaments qui en contiennent
FR2283674A1 (fr) Homo-steroides et medicaments qui en renferment
BE833064A (fr) D-homo-steroides et medicaments qui en renferment
FR2287232A1 (fr) Corticoides et medicaments qui en renferment
BE767702A (fr) Composes thiepinniques et medicaments qui en contiennent
BE837013A (fr) Oxo-20 homopregnanes et medicaments qui en contiennent

Legal Events

Date Code Title Description
ST Notification of lapse